Home › Calculator › ADXN Dividend Calculator 2026
ADXN Dividend DRIP Calculator 2026
34.16% YieldHealthcareAddex Therapeutics Ltd · NASDAQ
Price: $5.86 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When ADXN pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your ADXN snowball 📈
$10,000 in ADXN → $62490682.94M in 10 years · $5,192,711,538,023.74/month
About Addex Therapeutics Ltd (ADXN) — Dividend Analysis 2026
Addex Therapeutics Ltd, a biopharmaceutical firm in a developmental phase, operates out of Switzerland, focusing on the discovery, advancement, and commercialization of small-molecule drugs targeting central nervous system (CNS) disorders. Their core strategy involves identifying oral small-molecule allosteric modulators for G-protein coupled receptors. The company's key programs include Dipraglurant, an investigational treatment for Parkinson's disease levodopa-induced dyskinesia and dystonia; ADX71149, which is being developed for epilepsy and other unspecified CNS conditions; and GABAB PAM, a compound aimed at treating addiction. Addex Therapeutics has established licensing and collaboration agreements with significant partners, including Janssen Pharmaceuticals Inc., Indivior PLC, and The Charcot–Marie–Tooth Association. Founded in 2002 and based in Geneva, Switzerland, the company was initially known as Addex Pharmaceuticals Ltd before officially changing its name to Addex Therapeutics Ltd in March 2012.
Compare ADXN with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full ADXN DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ADXN position with:
🌍 ADXN Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold ADXN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 34.16% | 31.36% | $3,416 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 29.04% | 26.24% | $2,904 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 27.33% | 24.53% | $2,733 / yr |
| 🇬🇧 UK ISA | 0% | 34.16% | 31.36% | $3,416 / yr |
| 🇬🇧 UK Taxable | 8.75% | 31.17% | 28.37% | $3,117 / yr |
| 🇨🇦 TFSA | 0% | 34.16% | 31.36% | $3,416 / yr |
| 🇨🇦 CA Taxable | 25% | 25.62% | 22.82% | $2,562 / yr |
| 🇦🇺 Super (pension) | 15% | 29.04% | 26.24% | $2,904 / yr |
| 🇦🇺 AU Taxable | 30% | 23.91% | 21.11% | $2,391 / yr |
| 🇩🇪 DE Taxable | 26.375% | 25.15% | 22.35% | $2,515 / yr |
| 🇫🇷 FR Taxable | 30% | 23.91% | 21.11% | $2,391 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 ADXN Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 ADXN Dividend Payment Schedule
ADXN pays quarterly — 4 times per year. Next ex-div: TBD.
📊 ADXN vs Healthcare Benchmarks
How ADXN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ADXN sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ ADXN Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-09-02 | 100,485 | $0.03 | $3.2K | ||
| D-Return | 2026-09-02 | 10,000 | $0.16 | $1.6K | ||
| D-Return | 2026-09-02 | 30,000 | $0.16 | $4.8K | ||
| D-Return | 2026-09-02 | 37,770 | $0.16 | $6.0K | ||
| D-Return | 2026-09-02 | 59,530 | $0.16 | $9.5K | ||
| D-Return | 2026-09-02 | 65,620 | $0.16 | $10.5K | ||
| D-Return | 2026-09-02 | 90,529 | $0.16 | $14.5K | ||
| D-Return | 2026-09-02 | 100,485 | $0.06 | $6.2K | ||
| D-Return | 2026-09-02 | 208,974 | $0.05 | $11.1K | ||
| A-Award | 2026-09-02 | 306,765 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ADXN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Addex Therapeutics Ltd (ADXN) is currently trading at $5.86, 98% below its 52-week high. The current dividend yield is 34.16% based on an annual payout of $2.00 per share.
ADXN (Addex Therapeutics Ltd) — 34.16% Dividend Yield Analysis
Addex Therapeutics Ltd (ADXN) is a healthcare stock currently trading at $5.86 with a dividend yield of 34.16%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (34.16%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.